Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 855
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Ketoprocen 300 mg/ml V/DCP/21/0036 Cenavisa S.L, Spānija QM01AE03 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for use in drinking water
International name (active substance): Ketoprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Cenavisa S.L, Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0036-01 1 ABPE pudele, 500 ml -
Colivet oral solution - V/NRP/03/1617 Ceva Sante Animale', Francija QA07AA10 poultry; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Colistin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 22-Oct-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1617-01 1 Polietilēna flakons, 250 ml -
V/NRP/03/1617-02 1 Polietilēna flakons, 500 ml -
V/NRP/03/1617-03 1 Polietilēna flakons, 1 l -
V/NRP/03/1617-04 1 Polietilēna flakons, 2 l -
V/NRP/03/1617-05 1 Polietilēna flakons, 5 l -
CYLANIC - V/DCP/21/0041 Industrial Veterinaria, S.A., Spānija QJ01CR02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 24102025LI (24-Oct-2025)
Labelling text: [DOCX] 24102025M (24-Oct-2025)
Summary of product characteristics: [DOCX] 24102025ZA (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0041-01 1 Blisteris, 10 tablete -
V/DCP/21/0041-02 3 Blisteris, 10 tablete -
V/DCP/21/0041-03 5 Blisteris, 10 tablete -
V/DCP/21/0041-04 10 Blisteris, 10 tablete -
V/DCP/21/0041-05 25 Blisteris, 10 tablete -
CYLANIC - V/DCP/21/0042 Industrial Veterinaria, S.A., Spānija QJ01CR02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 24102025LI (24-Oct-2025)
Labelling text: [DOCX] 24102025M (24-Oct-2025)
Summary of product characteristics: [DOCX] 24102025ZA (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0042-01 1 Blisteris, 10 tablete -
V/DCP/21/0042-02 3 Blisteris, 10 tablete -
V/DCP/21/0042-03 5 Blisteris, 10 tablete -
V/DCP/21/0042-04 10 Blisteris, 10 tablete -
V/DCP/21/0042-05 25 Blisteris, 10 tablete -
Isaderm - V/NRP/03/1600 Dechra Veterinary Products A/S, Dānija QD07CC01 dogs Vairāk

Medicinal product information

Pharmaceutical form: gel
International name (active substance): Fusidic acid, Betamethasone valerate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release GENERA Inc., Horvātija
Date of authorisation/renewal: 08-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1600-01 1 Alumīnija tūba, 15 g -
V/NRP/03/1600-02 1 Alumīnija tūba, 5 g -
V/NRP/03/1600-03 1 Alumīnija tūba, 30 g -
Duelmint 40 - V/NRP/08/1568 Fatro S.p.A., Itālija QP52AC59 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Mebendazole,Praziquantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1568-01 1 Plastikāta tūbiņa, 15 ml -
Duelmint 20 - V/NRP/02/1489 Fatro S.p.A., Itālija QP52AC59 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Mebendazole,Praziquantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1489-01 1 Injektors, 15 ml -
Belacol 100% Compactate 1000 mg/g V/DCP/16/0027 Bela-pharm GmbH&Co.KG, Vācija QA07AA10 cattle; pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: granules for use in drinking water
International name (active substance): Colistin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 27-Oct-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0027-01 1000 mg/g 1 Kastīte, 250 g -
V/DCP/16/0027-02 1000 mg/g 1 Kastīte, 500 g -
V/DCP/16/0027-03 1000 mg/g 1 Kastīte, 1 kg -
V/DCP/16/0027-04 1000 mg/g 1 Kastīte, 2,5 kg -
Bovilis IBR Marker Inac - V/MRP/06/1675 Intervet International B.V., Nīderlande QI02AA03 cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated antigen of BHV-1 (gE) strain GK/D
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 16-Nov-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/06/1675-01 1 Stikla flakons, 5 deva -
V/MRP/06/1675-02 10 Stikla flakons, 5 deva -
V/MRP/06/1675-03 1 Stikla flakons, 10 deva -
V/MRP/06/1675-04 10 Stikla flakons, 10 deva -
V/MRP/06/1675-05 1 Stikla flakons, 25 deva -
V/MRP/06/1675-06 10 Stikla flakons, 25 deva -
V/MRP/06/1675-07 1 Stikla flakons, 50 deva -
V/MRP/06/1675-08 10 Stikla flakons, 50 deva -
V/MRP/06/1675-09 1 Stikla flakons, 100 deva -
V/MRP/06/1675-10 10 Stikla flakons, 100 deva -
V/MRP/06/1675-11 1 Plastmasas flakons, 5 deva -
V/MRP/06/1675-12 10 Plastmasas flakons, 5 deva -
V/MRP/06/1675-13 1 Plastmasas flakons, 10 deva -
V/MRP/06/1675-14 10 Plastmasas flakons, 10 deva -
V/MRP/06/1675-15 1 Plastmasas flakons, 25 deva -
V/MRP/06/1675-16 10 Plastmasas flakons, 25 deva -
V/MRP/06/1675-17 1 Plastmasas flakons, 50 deva -
V/MRP/06/1675-18 10 Plastmasas flakons, 50 deva -
V/MRP/06/1675-19 1 Plastmasas flakons, 100 deva -
V/MRP/06/1675-20 10 Plastmasas flakons, 100 deva -
Amoxibactin vet 50 mg V/DCP/14/0059 Le Vet Beheer B.V., Nīderlande QJ01CA04 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0059-01 50 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/14/0059-02 50 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-03 50 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-04 50 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-05 50 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-06 50 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-07 50 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-08 50 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-09 50 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-10 50 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-11 50 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-12 50 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-13 50 mg 10 Kastīte ar blisteri, 10 tablete -
Amoxibactin vet 250 mg V/DCP/14/0060 Le Vet Beheer B.V., Nīderlande QJ01CA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0060-01 250 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-02 250 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-03 250 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-04 250 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-05 250 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-06 250 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-07 250 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-08 250 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-09 250 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-10 250 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-11 250 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-12 250 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-13 250 mg 10 Kastīte ar blisteri, 10 tablete -
Amoxibactin vet 500 mg V/DCP/14/0061 Le Vet Beheer B.V., Nīderlande QJ01CA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0061-01 500 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-02 500 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-03 500 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-04 500 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-05 500 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-06 500 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-07 500 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-08 500 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-09 500 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-10 500 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-11 500 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-12 500 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-13 500 mg 10 Kastīte ar blisteri, 10 tablete -
Intra Hoof-Fit Gel - V/MRP/13/0017 Intracare BV, Nīderlande QD03 dairy cows Vairāk

Medicinal product information

Pharmaceutical form: gel
International name (active substance): Copper,Zinc
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Intracare BV, Nīderlande
Date of authorisation/renewal: 28-Apr-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0017-01 6 Polipropilēna konteiners, 430 g -
Boflox flavour 20 mg V/DCP/16/0041 Industrial Veterinaria, S.A., Spānija QJ01MA93 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 27-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0041-01 1 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-02 2 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-03 5 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-04 10 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-05 15 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-06 20 Al/Al blisteris, 10 tablete -
Boflox flavour 80 mg V/DCP/16/0042 Industrial Veterinaria, S.A., Spānija QJ01MA93 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 27-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0042-01 1 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-02 2 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-03 6 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-04 12 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-05 20 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-06 40 Al/Al blisteris, 6 tablete -
LV Ceftionel-50 50 mg/ml V/NRP/11/0065 Interchemie werken „De Adelaar“ LT, Lietuva QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 30-Nov-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 26102021LI (26-Oct-2021)
Labelling text: [DOCX] 26102021M (26-Oct-2021)
Summary of product characteristics: [DOCX] 26102021ZA (26-Oct-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/11/0065-01 50 mg/ml 1 Stikla pudele, 50 ml -
V/NRP/11/0065-02 50 mg/ml 1 Stikla pudele, 100 ml -
Depedin - V/NRP/92/0216 Veyx-Pharma GmbH, Vācija QH02AB30 cattle; pigs; horses; dogs; cats; piglets Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Dexamethasone, Prednisolone acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
Date of authorisation/renewal: 18-Mar-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOC] 190825LI (19-Aug-2025)
Labelling text: [DOC] 260422M (26-Apr-2022)
Summary of product characteristics: [DOC] 260422ZA (26-Apr-2022)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/92/0216-01 1 Stikla flakons, 50 ml -
V/NRP/92/0216-02 12 Stikla flakons, 50 ml -
Api-Bioxal 0.71 g/g V/MRP/21/0019 Chemicals Laif S.p.A., Itālija QP53AG03 honey bees Vairāk

Medicinal product information

Pharmaceutical form: Powder for in-hive use
International name (active substance): Oxalic acid dihydrate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chemifarma S.p.A., Itālija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Jun-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Jun-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Jun-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0019-01 0,71 g/g 1 Maisiņš, 35 g -
V/MRP/21/0019-02 0,71 g/g 1 Maisiņš, 175 g -
V/MRP/21/0019-03 0,71 g/g 1 Maisiņš, 350 g -
Suxibuzone Ecuphar 1.5 g V/DCP/20/0057 Ecuphar NV, Beļģija QM01AA90 horses; ponies Vairāk

Medicinal product information

Pharmaceutical form: granules
International name (active substance): Suxibuzone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Meribel Pharma Parets S.L., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0057-01 1,5 g 18 Paciņa, 3 g -
V/DCP/20/0057-02 1,5 g 60 Paciņa, 3 g -
Veyxyl® LA 20% 200 mg/ml V/NRP/99/1035 Veyx-Pharma GmbH, Vācija QJ01CA04 cattle; pigs; sheep; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Veyx-Pharma GmbH, Vācija
Date of authorisation/renewal: 07-Aug-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 23102020LI (23-Oct-2020)
Labelling text: [PDF] 09112018M (09-Nov-2018)
Summary of product characteristics: [DOCX] 23102020ZA (23-Oct-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/1035-01 200 mg/ml 1 Flakons, 100 ml -

3081 record

© Food and veterinary service · 2026 Cookies policy